ClinicalTrials.gov
public full text
Public Domain
Chromium Picolinate for the Treatment of Metabolic Syndrome
blood-glucosecholesterolchromiumcomplementary-therapiesinsulin-resistancemetabolic-diseasesmetabolic-syndrome-xna
The purpose of this study is to determine whether chromium supplements can reduce symptoms of metabolic syndrome, a collection of symptoms that increase one's risk for developing heart disease, stroke, and diabetes.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Novel Therapy for Glucose Intolerance in HIV Disease#901259
- Dietary Modification Intervention Involving Family Support (FamNUTRI) for Managing Sarcopenic Obesity Among Community-dwelling Older Adults#827446
- Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation#6209
- Magnesium and Metabolic Syndrome#67727
- Effects of Diet Changes on Metabolism#854878
Record · ID 1101711
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive